COVID-19 Deaths Rise After A 5-Week Decline

GENEVA — After five weeks of declining coronavirus deaths, the number of fatalities reported globally increased by 4% last week, according to the World Health Organization.

According to the U.N., there have been 8700 deaths of COVID-19 since Thursday’s U.N. Health Agency Weekly Assessment. The U.S. reported that the Americas saw a 21% increase and the Western Pacific saw a 17% rise.

WHO stated that the number of coronavirus-related cases fell with an additional 3.2 million cases being reported last week. This extends the decline in COVID-19 cases since January. However, significant infections were reported in certain regions. The Middle East and Southeast Asia saw an increase of 58% and 33%, respectively.

Learn More Black Americans Feel Shocked by COVID-19.

“Because many countries have reduced surveillance and testing, we know this number is under-reported,” WHO Director-General Tedros Adhanom Ghebreyesus said earlier this week. He said there was “no acceptable level of deaths from COVID-19,” given that the global community now has the vaccines, medicines and diagnostics to stop the virus.

While many rich countries in Europe and North America have mostly dropped their virus restrictions, China’s extreme COVID-19 policies have meant more mass testing, quarantines and sequestering of anyone who was in contact with a case.

China’s capital put school back online this week in one of its major districts amid a new COVID-19 outbreak linked to a nightclub. Residents in Beijing are still undergoing regular testing — mostly every other day — and must wear masks and swipe a mobile phone app to enter public places and facilitate case tracing.

China has maintained its “zero-COVID” policy despite considerable economic costs and an assertion from the head of the World Health Organization that the policy isn’t sustainable.

Learn More The Rising Costs of China’s Zero-COVID Policy

This week, U.S. officials moved a step closer to authorizing coronavirus vaccines for the youngest children, after the Food and Drug Administration’s vaccine advisers gave a thumbs-up to vaccines from Moderna and Pfizer-BioNTech for children under 5.

The outside experts voted unanimously that the benefits of the shots outweigh any risks for children under 5 — that’s roughly 18 million youngsters. These children are among the most vulnerable in America and have not been vaccinated with COVID-19. Parents worry about their kids’ health.

After all steps have been completed, the shots can be ordered next week.

Read More From Time

Get in touchAt


Related Articles

Back to top button